Metabolism and pharmacokinetics of dibromodulcitol (DBD, NSC-104800) in man. I. Metabolites of DBD

Toxicity, hæmatological effects and anti-tumour activity of epoxides derived from disubstituted hexitols. Mode of action of mannitol myleran and dibromomannitol

L. A. Elson, Michael Jarman, W. C. J. Ross · European Journal of Cancer (1965) · 1968 · 56 citations

Medicine, Medicinal Chemistry, Pharmacology +6

A mouse ependymoblastoma as an experimental model for screening potential antineoplastic drugs.

Ruth I. Geran, George Congleton, Leo Dudeck et al. · PubMed · 1974 · 56 citations

Medicine, Oncology, Pharmacology +16

The absorption and metabolism of dibromodulcitol in patients with advanced cancer

Miroslaw A. Belej, William M. Troetel, Andreas Weiss et al. · Clinical Pharmacology & Therapeutics · 1972 · 29 citations

Medicine, Oncology, Pharmacology +13

Clinical and pharmacologic experience with dibromodulcitol (NSC-104800). A new antitumor agent.

C Sellei, Shohreh B. Eckhardt, I Horváth et al. · PubMed · 1969 · 20 citations

Medicine, Oncology, Pharmacology +8

Some characteristic features of the biotransport of the cytostatic agent 1,6‐dibromo‐1,6‐dideoxy‐dulcitol

László Institóris, I.P. Horváth, G. Pethes · International Journal of Cancer · 1967 · 13 citations

Medicine, Pharmacokinetics, Pharmacology +16